Current Report Filing (8-k)
26 10월 2018 - 8:17PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
______________
FORM 8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
Report (Date of earliest event reported):
October
26, 2018
______________
LIFEPOINT HEALTH, INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
000-51251
|
20-1538254
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
330 Seven Springs Way
Brentwood, Tennessee
|
37027
|
(Address
of principal executive offices)
|
(Zip
Code)
|
615-920-7000
(
Registrant’s
telephone number, including area code)
N/A
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
⃞
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
⃞
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
⃞
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
⃞
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934
(§240.12b-2 of this chapter).
Emerging growth company
⃞
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.
⃞
Item 2.02
|
Results of Operations and Financial Condition.
|
On October 26, 2018, LifePoint Health, Inc. (the "Company") issued a
press release announcing results for the third quarter and nine months
ended September 30, 2018. See the press release attached as Exhibit
99.1.
Item 9.01.
|
Financial Statements and Exhibits.
|
|
(d)
|
Exhibits.
|
|
|
|
99.1
|
Copy of press release issued by the Company on October 26, 2018.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date:
|
October 26, 2018
|
LIFEPOINT HEALTH, INC.
|
|
|
|
|
|
By:
|
/s/ Michael S. Coggin
|
|
|
|
|
|
|
|
Michael S. Coggin
|
|
|
|
Executive Vice President and Chief Financial Officer
|
EXHIBIT INDEX
LifePoint Health, Inc. (NASDAQ:LPNT)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
LifePoint Health, Inc. (NASDAQ:LPNT)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Lifepoint Health, Inc. (delisted) (나스닥)의 실시간 뉴스: 최근 기사 0
More Lifepoint Health, Inc. News Articles